Drug Trial Radar · NCT07587047
Adia Med of Winter Park LLC Lower Back Pain Research Study
Last checked: Nov 20, 2026Latest source record: Jun 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
100
Planned (sponsor's estimate)
Start
Jun 16, 2026
Primary completion
Jan 2028
Study completion Jan 2028
Sponsor
- Lead sponsor
- Adia Med of Winter Park LLCAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- May 14, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this clinical study is to evaluate the safety and preliminary efficacy of an investigational umbilical cord blood-derived stem cell and exosome infusion in adults with chronic lower back pain associated with degenerative spine disease. The primary questions this study aims to answer are whether the investigational infusion is safe and well tolerated and whether treatment may reduce pain and improve physical function and quality of life. Researchers will compare the investigational infusion to a placebo (saline solution) to evaluate potential treatment effects in participants with chronic mechanical lower back pain. Participants will receive either the investigational infusion or placebo intravenously during a study visit, complete pain, disability, and quality-of-life assessments, undergo magnetic resonance imaging (MRI) and laboratory testing, and attend follow-up evaluations over a 6-month period. Participants initially assigned to placebo may later receive the investigational treatment during an open-label crossover phase of the study.
Conditions
- Chronic Mechanical Lower Back Pain
- Lower Back Pain
- Chronic Lower Back Pain
Interventions
Umbilical Cord Blood-Derived Stem Cells and ExosomesBiological
Intravenous infusion of cryopreserved allogeneic umbilical cord blood-derived product containing viable mononuclear cells (including hematopoietic and mesenchymal stem/stromal cells) and exosomes.
Placebo IVOther
Matched placebo intravenous infusion (administered in the same volume and manner as stem cell and exosome product).
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Average Low Back Pain Intensity From Baseline to Month 3Time frame: Baseline to Month 3
- Change in Functional Disability From Baseline to Month 3Time frame: Baseline to Month 3
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Adia Med Of Winter Park
Winter Park, Florida · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.